Fig. 5.
Quality of life measurement. (A) The difference between baseline and each time point in global health and functional subscales. Positive values meant improved state compared with baseline. (B) The change in symptom subscales from baseline. In contrast to functional subscales, negative values meant improved state. IX, irinotecan and capecitabine combination; X, capecitabine. *p > 0.05.